Artelo Biosciences Files 8-K on Security Holder Vote
Ticker: ARTL · Form: 8-K · Filed: Aug 29, 2025 · CIK: 1621221
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
Related Tickers: ARTL
TL;DR
ARTL filed an 8-K for a shareholder vote on 8/28. Details TBD.
AI Summary
Artelo Biosciences, Inc. filed an 8-K on August 29, 2025, reporting on a matter submitted to a vote of its security holders on August 28, 2025. The filing does not disclose the specific details of the vote or the outcome.
Why It Matters
This filing indicates a significant corporate action requiring shareholder approval, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: medium — The filing is a routine 8-K for a shareholder vote, but the lack of specific details about the vote's subject and outcome introduces uncertainty.
Key Players & Entities
- ARTELO BIOSCIENCES, INC. (company) — Registrant
- August 28, 2025 (date) — Date of earliest event reported
- August 29, 2025 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- 001-38951 (company_id) — SEC File Number
FAQ
What was the specific matter submitted to a vote of Artelo Biosciences' security holders?
The filing does not specify the subject of the vote.
When did the vote by security holders take place?
The earliest event reported, which is the date of the vote, was August 28, 2025.
What was the outcome of the vote?
The filing does not disclose the outcome of the vote.
What is Artelo Biosciences' state of incorporation?
Artelo Biosciences, Inc. is incorporated in Nevada.
What is the SEC file number for Artelo Biosciences?
The SEC file number for Artelo Biosciences, Inc. is 001-38951.
Filing Stats: 679 words · 3 min read · ~2 pages · Grade level 11.6 · Accepted 2025-08-29 16:43:38
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share ARTL The Nasdaq Stock Mar
Filing Documents
- artl_8k.htm (8-K) — 33KB
- 0001640334-25-001613.txt ( ) — 148KB
- artl-20250828.xsd (EX-101.SCH) — 5KB
- artl-20250828_lab.xml (EX-101.LAB) — 15KB
- artl-20250828_cal.xml (EX-101.CAL) — 1KB
- artl-20250828_pre.xml (EX-101.PRE) — 9KB
- artl-20250828_def.xml (EX-101.DEF) — 2KB
- artl_8k_htm.xml (XML) — 4KB
07 Submission of Matters to a Vote of Security Holders
ITEM 5.07 Submission of Matters to a Vote of Security Holders. We held a Special Meeting of Stockholders (the "Special Meeting") on August 28, 2025. Of the 704,425 shares of our common stock, par value $0.001 ("Common Stock"), outstanding as of the record date of July 25, 2025, 365,886 shares were represented at the Special Meeting, either by proxy or by attending the meeting. The matters voted on at the Special Meeting and the votes cast with respect to each such matter are set forth below: 1. Amendment to our Articles of Incorporation, as amended (the "Articles"), to increase the authorized number of shares of Common Stock from 8,333,333 shares to 500,000,000 shares. The amendment to the Articles to increase the authorized number of shares of Common Stock from 8,333,333 shares to 500,000,000 shares was approved based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 325,388 38,731 1,767 0 2. Amendment to our Articles to increase the number of authorized shares of preferred stock, par value $0.001 ("Preferred Stock"), from 69,444 to 10,000,000 and to authorize the issuance of 10,000,000 shares of Preferred Stock with rights and preferences to be determined by the Company's Board of Directors (the "Board") from time to time. The amendment to the Articles to increase the number of authorized shares of Preferred Stock from 69,444 to 10,000,000 and to authorize the issuance of 10,000,000 shares of Preferred Stock with rights and preferences to be determined by the Board from time to time was not approved based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 63,903 130,740 782 170,461 3. Ratification of Appointment of Independent Registered Public Accounting Firm. The appointment of Malone Bailey LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified based on the following results of voting: Vot
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ARTELO BIOSCIENCES, INC. Date: August 29, 2025 /s/ Gregory D. Gorgas Gregory D. Gorgas President & Chief Executive Officer 3